As home builders try to gain more business, more will be going after the entry-level buyer, real estate expert Bradley Hunter told CNBC Wednesday.» Read More
Seventy percent of the JetBlue pilots have voted to join ALPA, reports CNBC's Phil LeBeau.
Robert Olstein, Olstein Capital Management, and Herb Greenberg, CNBC contributor, discuss whether some companies are abusing how they report quarterly results.
Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.
CNBC's "Earnings Squad," has a look at three names to watch before they report earnings.
Jed Kolko, Trulia chief economist, discusses whether home ownership is the best long-term investment for most Americans.
CNBC's Diana Olick takes a look at what's prompting the slump in existing home sales.
CNBC's Meg Tirrell; Herb Greenberg, CNBC contributor, and Arindam Nag, Mergermarket, discuss potential takeover targets in the pharmaceutical space.
The latest delay in the Keystone XL pipeline is all about politics, and not about the reality of pipelines, said John Hofmeister.
The Lefty mayors of NY and LA talk about income equality but when it comes to Hollywood and taxes, they're starry-eyed, says Jake Novak.
"Captain America: The Winter Soldier" was filmed in Cleveland and created 2,800 jobs and contributed $35 million to the state of Ohio. Joe Henchman, Tax Foundation, and Douglas Steiner, Steiner Studios Chairman, discuss state tax credits.
CNBC's Scott Cohn reports from Boston on the high level of support, as well as security at this year's Boston Marathon.
Discussing a report Nike fired its entire FuelBand crew, and when wearables will be embraced, with Lauren Goode, Re/code tech reporter.
Reports indicate Ford is said to name Mark Fields as the next CEO of the auto company, with CNBC's Phil LeBeau.
What to expect from the earnings of Netflix, AK Steel, McDonald's and Simon Property Group, with CNBC's Melissa Lee, Courtney Reagan and Dominic Chu.
Discussing another delay for the Keystone XL pipeline, and the politics involved in moving the project forward, with John Hofmeister, former Shell Oil president.
Supporters of the Keystone Pipeline say it is critical to the North American oil boom, reports CNBC's Jackie DeAngelis. The Obama administration has added an additional delay in the program.
Discussing the pullback in biotech, with Paul Hickey, Bespoke Investment Group.
Sarepta Therapeutics CEO Chris Garabedian discusses the prospects for what he calls a "potential accelerated approval" for its Duchenne muscular dystrophy drug Eteplirsen.
Sarepta Therapeutics is developing a drug for Duchenne muscular dystrophy. Its CEO Chris Garabedian discusses challenges the drug Eteplirsen has faced before the FDA.
Sarepta Therapeutics got the go-ahead to file for approval of its experimental drug for Duchenne muscular dystrophy.